<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03734042</url>
  </required_header>
  <id_info>
    <org_study_id>PRPF</org_study_id>
    <nct_id>NCT03734042</nct_id>
  </id_info>
  <brief_title>PRP Intrauterine Infusion in Thawed Embryo Cycles</brief_title>
  <official_title>Intrauterine Infusion of Platelet-rich Plasma Before Thawed Embryo Transfer: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients prepared to thawed embryo transfer were classified into 2 groups one group will
      receive platelet rich plasma (PRP) infusion intrauterine and the other group will not receive
      platelet rich plasma (PRP) infusion
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients candidates for Thawed embryo transfer were recruited from 3 centers and classified
      into 2 groups:

      Group I: Will receive platelet rich plasma (PRP) intrauterine infusion at day 11

      Group II: Not receiving platelet rich plasma (PRP)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups parallel</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endometrial thickness</measure>
    <time_frame>8 days</time_frame>
    <description>The increase in endometrial thickness at day of ET</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>15 days</time_frame>
    <description>Number of cases who got pregnant</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Evaluations</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients will receive platelet rich plasma intrauterine infusion at day 11</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>These patients will receive intrauterine normal saline infusion at day 11</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelet rich plasma intrauterine infusion</intervention_name>
    <description>platelet rich plasma will be prepared, activated then infused by Intrauterine insemination catheter intrauterine at day 11</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Intrauterine infusion of normal saline at day 11</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient wishing to transfer thawed embryos

          -  Patient who had freeze all in previous cycle

        Exclusion Criteria:

          -  patients older than 35 years

          -  patients with history of failed IVF/ICSI

          -  patients desiring fresh embryo transfer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ayman Dawood</last_name>
    <phone>+201020972067</phone>
    <email>ayman.dawood@med.tanta.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adel Elgergawy</last_name>
    <phone>+201002057250</phone>
    <email>dradelali775@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ayman Shehata Dawood</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Elhalwagy</last_name>
    </contact>
    <contact_backup>
      <email>halwagy22@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ayman S Dawood, MD</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Platelet rich plasma</keyword>
  <keyword>Intrauterine infusion</keyword>
  <keyword>Thawed embryos</keyword>
  <keyword>IVF/ICSI cycles</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>not allowed</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

